Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 51Infertility 21Anovulation 10Vitamin D Deficiency 2Rare Diseases 2Hyperinsulinism 2Hyperandrogenism 2Endocrine System Diseases 2Prolactinoma 1Primary Ovarian Insufficiency 1Pathologic Processes 1Motor Activity 1Leiomyoma 1Insulin Resistance 1Infertility, Female 1Hypogonadism 1Hyperprolactinemia 1Dry Eye Syndromes 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3selpercatinib 2parathyroid hormone-related peptide (1-36) 2niraparib 2Ocoxin 2Musculoskeletal Manipulations 2Metformin 2Clomiphene 2Cisplatin 2repotrectinib 1relacorilant 1pralsetinib 1pembrolizumab 1napabucasin 1lutetium Lu 177 dotatate 1fluorodopa F 18 1copper dotatate CU-64 1anlotinib 1adrenosterone 1Ultrasonography 1Thalidomide 1Sunitinib 1Spironolactone 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Paclitaxel 1Octreotide 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endocrine System Diseases × Clomiphene × Clear all
NCT00005104 2005-06-24

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

National Center for Research Resources (NCRR)

Phase NA Completed
99 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

NCT00005654 2005-06-24

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Office of Rare Diseases (ORD)

Phase NA Completed
88 enrolled

Endocrine System Diseases, Hyperinsulinism, Polycystic Ovary Syndrome, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡